Onderzoeker
Emily Van San
- Disciplines:Andere medische en gezondheidswetenschappen niet elders geclassificeerd
Affiliaties
- Vakgroep Biomedische Moleculaire Biologie (Departement)
Lid
Vanaf8 nov 2017 → 24 sep 2023
Publicaties
1 - 5 van 5
- Ferroptosis contributes to multiple sclerosis and its pharmacological targeting suppresses experimental disease progression(2023)
Auteurs: Emily Van San, Angela Debruyne, Geraldine Veeckmans, Yulia Y. Y. Tyurina, Vladimir A. A. Tyurin, Hao Zheng, Sze Men Choi, Koen Augustyns, Geert van Loo, Bernhard Michalke, et al.
Pagina's: 2092 - 2103 - Targeting ferroptosis protects against experimental (multi)organ dysfunction and death(2022)
Auteurs: Samya Van Coillie, Emily Van San, Ines Goetschalckx, Bartosz Wiernicki, Banibrata Mukhopadhyay, Wulf Tonnus, Ria Roelandt, Catalina Dumitrascu, Ludwig Lamberts, Geert Dams, et al.
- Viral dosing of influenza A infection reveals involvement of RIPK3 and FADD, but not MLKL(2021)
Auteurs: Teodora-Eugenia Oltean, Emily Van San, Tatyana Divert, Tom Vanden Berghe, Jonathan Maelfait, Nozomi Takahashi, Peter Vandenabeele
- Emerging immune and cell death mechanisms in stroke : saponins as therapeutic candidates(2020)
Auteurs: Laura García-Pupo, Emily Van San, René Delgado-Hernández, Tom Vanden Berghe, Wim Vanden Berghe
- Fatal lymphocytic cardiac damage in coronavirus disease 2019 (COVID-19) : autopsy reveals a ferroptosis signature(2020)
Auteurs: Werner Jacobs, Martin Lammens, Annelies Kerckhofs, Evy Voets, Emily Van San, Samya Van Coillie, Cedric Peleman, Matthias Mergeay, Sabriya Sirimsi, Veerle Matheeussen, et al.